Streetbeat News

Earnings

TAST

Carrols Restaurant Group, Inc. (NASDAQ:TAST) reported Q4 restaurant sales growth of 5.7% YoY, reaching $470.4M. Burger King and Popeyes, part of Carrols' portfolio, saw comparable sales growth of 7.2% and 7.6% YoY, respectively. Full-year sales rose 8.4% to $1.88B, with Burger King and Popeyes comparable sales up 9.3% and 10.1%. The company expects Q4 adjusted EBITDA to be at or slightly above the high end of the $28M-$32M range, with full-year adjusted EBITDA also at the high end or above the $145M-$149M range.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:13 pm

HELE

Helen of Troy has reaffirmed its commitment to one-time pre-tax restructuring charges estimated between $60M and $65M over the course of Project Pegasus. This reaffirmation indicates that the company is proceeding with its restructuring plans, which are expected to incur significant costs.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:11 pm

TVTX

Travere Therapeutics reported ending 2023 with around $567M in cash, cash equivalents, and marketable securities, which is anticipated to fund its operations until 2028.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:11 pm

TVTX

Travere Therapeutics reported receiving 459 new patient start forms for Filspari (Sparsentan) in Q4 2023. Preliminary net product sales for Filspari reached $15M in Q4 and totaled $30M since its commercial launch in February 2023.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:10 pm

TVTX

Travere Therapeutics forecasts Q4 FY23 net product sales from continuing operations to be around $40M, with an estimated $128M for the full fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:10 pm

PBPB

Potbelly Corporation reported preliminary Q4 same-store sales growth of 5.9% to 6.4%. CEO Bob Wright attributed the growth to the successful execution of their Five-Pillar Strategy, with a notable increase in traffic contributing to the rise. The company's average weekly sales also surpassed the high end of their previous guidance.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:10 pm

FIVE

Five Below, Inc. reported a 15.6% increase in holiday sales, reaching $1.16 billion, and expects Q4 results to be in the upper range of its guidance ($1.32B-$1.35B in sales and $3.64-$3.80 in EPS). The company saw a 3.6% increase in comparable sales during the holiday period and is reiterating its EPS outlook. Five Below opened a record 204 net new stores in fiscal 2023 and is focusing on its Triple-Double strategy for further growth.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:09 pm

STAA

STAAR Surgical reported preliminary net sales of $76.5 million for Q4, surpassing estimates of $74.23 million. For the full year 2023, the company expects approximately $322.5 million in net sales, slightly above the estimated $320.5 million.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:07 pm

CROX

Crocs Inc. forecasts a revenue growth of 3% to 5% for 2024 over 2023, with the Crocs brand expected to grow 4% to 6% and the HEYDUDE brand projected to be flat to slightly up.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:04 pm

CROX

Crocs, Inc. has projected its Q4 2023 revenues to increase by over 1% year-over-year, surpassing its previous guidance which anticipated a decline of 4% to 1%.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:03 pm